Life Sciences

Companies Life Sciences

BioTek Instruments GmbH, Germany

BioTek is a leading developer and supplier of high-value microplate instrumentation and software solutions. Our instrumentation is used to accelerate the drug discovery process, to advance discoveries in genomics and proteomics, and to aid in the advancement of life science research. As part of the more

BRAND GMBH + CO KG, Germany

Manufacturer of Liquid Handling Instruments (dispensers, burettes, manual and electronic single-/multichannel pipettes as well as manual and electronic repetitive pipettes), volumetric glassware, plasticware for Life Science (PCR, storage, HTS/ UHTS, UV-disposable cuvettes) and analysis, also made f more

Products Life Sciences

Sterile plates enhance cellular growth applications

BactiGrowth plates from Porvair Sciences Ltd. offer a contamination free deep-well microplate optimised for high yield growth of bacteria, yeast and more

Eppendorf’s new Mastercycler nexus X1 provides short PCR run times and low power consumption

The new Mastercycler nexus X1 from Eppendorf is the latest addition to the Mastercycler range of PCR instruments. It provides researchers with increased heating more

Catalogues Life Sciences

One Catalogue, 230 Top Brands, 31,100 Products – Compiled by Fisher Scientific for Your Lab Demands

The Fisher Scientific Catalogue presents the top product range for your lab applications including 10,000 new products and 30 new brands more

News Life Sciences

• Humboldt Foundation cooperates with Bayer Foundation

  The Alexander von Humboldt Foundation and the Bayer Science & Education Foundation will soon be awarding joint research fellowships. Until 2018, the Bayer Foundation will be making around three million EUR available to fund approximately ten Humboldt-Bayer Research Fellowships annually. The fellows more

• NanoString Technologies Completes $15.3 Million Series E Financing

  NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostic products, announced the completion of a $15.3 million Series E Preferred Stock issuance. New investors in the transaction included Morgan Stanley Expansion more

• Thermo Fisher Scientific Opens New Manufacturing Facility in China

  Thermo Fisher Scientific Inc. announced the official opening of its new facility in Suzhou, China, for the manufacturing of life sciences consumables and equipment. The facility expands the company’s global manufacturing footprint and establishes local production capabilities to meet increased custo more

White papers Life Sciences

• The New Genome Sequencer FLX System
  

  In 2005, the Genome Sequencer 20 System was introduced into the global life science market. Based on the revolutionary 454 sequencing technology, this system is able to generate hundreds of thousands of sequence reads in a few hours at a fraction of costs compared with the traditional Sanger technology. more

• Half a Century of Chromatography with Agilent and Predecessors
  

  Twsett originated the chromatography with his work about the separation of chlorophyll in 1903. For some time it was relatively quite around this new technology. Exceptions were the workings of Kuhn and Lederer (1931) as well as of Hesse (1936 and 1942). A break through succeeded to E. Cremer during the 40ies, but hardly considered caused by the war events, what however in the years 1950/51 by the conception of the gas chromatography suddenly changed and involved a rapid development more

• Array Capture-mediated Resequencing Leads to the Discovery of Four Novel Mutations in the Mouse
  

  By using array-based sequence capture and pyrosequencing to sequence an allelic series from the classically defined Kit locus (~200 kb) from each of five noncomplementing Kit mutants (one known allele and four unknown alleles), D'Ascenzo and co-workers discovered and validated a nonsynonymous coding mutation for each allele. These data represent the first documentation and confirmation of the fact that the new technologies can be used to efficiently discover causative mutations. Importantly, these results also provide the framework for constructing the efficient detection of causative mutations in mutant mouse strains moving forward. The standards presented here, coupled with the latest sequence capture methods (e.g., whole-exome arrays or solution-based methods) and next-generation sequencing technologies, promise to signicantly close the gap between phenotype and genotype in the mouse more

Publications Life Sciences

• Viewpoints in clinical proteomics – bringing proteomics into the clinic: The need for the field to finally take itself seriously

  Proteomics has fast become a standard tool in the life sciences, with increasingly sophisticated approaches and instruments delivering ever growing numbers of identified and quantified proteins. Yet despite the enormous technological progress, and the triumphant papers published on whole‐cell prot more

• Application of mass spectrometry to molecular diagnostics of viral infections

  Mass spectrometry (MS) has found numerous applications in life sciences. It has high accuracy, sensitivity and wide dynamic range in addition to medium- to high-throughput capabilities. These features make MS a superior platform for analysis of various biomolecules including proteins, lipids, nuclei more

• Resilience in the proteomics data ecosystem: how the field cares for its data

  The public dissemination of data is an integral part of the life sciences. In the field of proteomics too, data sharing has taken off over the last few years, with the first downstream uses of these data quickly gaining prominence. At the same time, the recent unfortunate demise of two repositorie more

Market studies Life Sciences

• South Korea Pharmaceuticals and Healthcare Report Q3 2012

  BMI View: A key theme in the South Korean pharmaceutical market is the government's incessant pharmaceutical price cuts that have created a cloud of uncertainty over the sector. In addition, a price cut announced in August 2011 is set to be effective later in 2012, which will mean an average 17% pri more

• Cloud Computing in Pharmaceutical Research and Development - Virtualization of Data through the Cloud Optimizes Next-Generation DNA Sequencing and Clinical Trials Data Management

  GBI Research, leading business intelligence provider has released its latest report, “Cloud Computing in Pharmaceutical Research and Development - Virtualization of Data through the Cloud Optimizes Next-Generation DNA Sequencing and Clinical Trials Data Management”, which provides insights into the more

• OptumInsight - Strategic SWOT Analysis Review

  OptumInsight - Strategic SWOT Analysis Review Summary Ingenix, Inc.(Ingenix), also known by OptumInsight is a health care data company, engaged in providing health information, technology and consulting services to healthcare industry. Ingenix is a subsidiary of UnitedHealth Group. Ingenix's info more

Websites Life Sciences